The CREDIBLE destination for everything Long Covid | Dr. Funmi Okunola MD
🩺 Certified CPD/CEU/CME for Licensed Medical Professionals.
Find your answers!
Why don’t all #LongCOVID studies tell the same story?
Dr Odilia Corneth explains why different patient groups may show different biological patterns, and why disease duration matters.
Understanding these differences could be key to more targeted treatments.
#ISLCPAIS#MEcfs
Could the gut play a bigger role in #LongCOVID and #MEcfs?
Prof Eva Untersmayr explains how changes to the gut barrier and microbiome may contribute to low-grade inflammation.
Her team has found these changes in both Long COVID and ME/CFS patients.
#ISLCPAIS#LongCOVIDResearch
Could a new approach help people with #LongCOVID?
Prof @PutrinoLab shared early findings on microtesla magnetic therapy. The small trial found improvements in some cognitive measures, with 100% adherence and no reported adverse events.
A larger trial is now planned.
#ISLCPAIS
Romina Foster Bonds shares the extraordinary response to the tirzepatide #LongCOVID trial.
1,058 participants enrolled in 73 days, with ~95.5% completing all surveys at 6 months.
People with Long COVID want answers. They’re ready to contribute to research.
#LongCOVIDResearch
What happens when recovery remains out of reach?
Dr Odelia Corneth followed severely affected #LongCOVID patients for ~2½ years. Many had PEM, were homebound and functioning at just 20–30% of their pre-COVID level.
Only a handful showed improvement.
#ISLCPAIS#MEcfs
Could abnormal blood clots help explain #LongCOVID?
Prof Doug Kell and Prof @resiapretorius discuss research into amyloid, fibrin and abnormal clots, and how spike protein may contribute to changes in clot structure.
Could this help explain persistent symptoms?
#ISLCPAIS
Could a 15-Minute Treatment Help Long COVID Brain Fog? At ISLC-PAIS, Dr. Blake Gurfein, founder of Therion, explains microtesla magnetic therapy (MMT), a non-invasive approach being investigated for cognitive impairment in Long COVID. #LongCOVID#BrainFog#MEcfs#ISLCPAIS
Could Some Long COVID Patients Need Someone Else’s Mitochondria?
Prof @PutrinoLab discusses different patterns of mitochondrial dysfunction in #LongCOVID & research into whether healthy donor mitochondria could one day be explored for patients with severe dysfunction.
What Can STIMULATE Teach Us About Long COVID?
Professor Melissa Heightman shares insights from the STIMULATE-ICP programme, exploring rehabilitation, MRI and repurposed medicines, and what the findings could mean for future research.
#LongCOVID#ISLCPAIS#MEcfs@LongCovidSOS
The power of collaboration.
ISLC-PAIS Chair Professor @RobWust reflects on bringing researchers from around the world together to tackle Long COVID, ME/CFS and other PAIS.
New ideas. New research. New trials.
The work continues.
#ISLCPAIS#LongCOVID#MEcfs#PAIS
ISLC-PAIS 2026 Young Investigator Award
Huge congratulations to Dr. @DaniBeckman on receiving the ISLC-PAIS 2026 Young Investigator Award, recognition of her outstanding research into Long COVID and post-acute infection syndromes.
#ISLCPAIS#LongCOVID#PAIS#MEcfs
Could Mitochondrial Transplantation Open New Research Avenues?
At #ISLCPAIS, Professor @PutrinoLab discusses pioneering research into mitochondrial transplantation, an experimental approach aimed at restoring cellular energy.
#LongCOVIDTheAnswers#longcovid
8 Years to an #MECFS Diagnosis.
Trude Schei of the Norwegian ME Association shares findings from a 2024 survey of 3,000+ people, including 500+ who became ill before 18.
Average time to diagnosis: 8 years.
Earlier recognition could mean earlier support.
#PAIS
Could PGE2 Hold Clues to #LongCOVID?
At #ISLCPAIS, citizen scientist Vera Ramer presents her hypothesis exploring how prostaglandin E2 (PGE2) and its receptors may influence #inflammation, pain & #fatigue in Long COVID.
An intriguing hypothesis for researchers to explore.
#PAIS
At #ISLCPAIS, neuroscientist Dr. @DaniBeckman shares advanced microscopy research exploring SARS-CoV-2 remnants & neuroinflammation in the brain.
Using 3D imaging, her team is developing models to better understand neurological symptoms in Long COVID.
#LongCOVID#NeuroCOVID
Behind every patient is a story.
At #ISLCPAIS, Dr. Funmi Okunola speaks with Shauna, whose partner Ro lives with very severe #MECFS and requires full-time care.
Their story reminds us why research, understanding and answers matter.
#LongCOVID#PAIS
Final Day at #ISLCPAIS in Amsterdam 🇳🇱
After a packed week of science and discussion, the final sessions explore viral persistence vs. autoimmunity, treatment without guidelines, and disease mechanisms in PAIS.
So much still to learn.
#LongCOVID#MECFS#PAIS
Long COVID Needs a Consensus Definition.
At #ISLCPAIS, Professor Michael Peluso highlights why clearer, consistent definitions for Long COVID in adults and children are essential for better research, and ultimately better answers.
#LongCOVID#PAIS#longcovidtheanswers